Milk protein shows promise in preventing deadly infections in preemies

NCT ID NCT07480434

Completed Prevention Sponsor: Zartash Sial Paeds Med Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether giving a protein called lactoferrin (found in milk) to premature babies could help prevent sepsis, a severe infection. The trial included 180 preterm infants with low birth weight, who received lactoferrin or a placebo within 72 hours of birth. The goal was to see if this simple supplement could reduce the risk of sepsis in this vulnerable group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bovine lactoferrin (a protein from cow's milk)
What this could lead to: If it works, this could point toward a simple, safe way to reduce life-threatening infections in premature babies.
What could go wrong: This was a small, early-phase study (Phase 1) with only 180 participants. Results may not be conclusive, and larger trials are needed to confirm any benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Sepsis infectious disease with sepsis prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEPSIS

Contacts and locations

Locations

King Edward Medical University Lahore

Lahore, Punjab Province, 54000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.